@article{74dc16c787a14481874f117e30bdac74,
title = "After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries",
keywords = "Arthritis, Rheumatoid, Therapeutics, Antirheumatic Agents, ACTIVE RHEUMATOID-ARTHRITIS, INADEQUATE RESPONSE, SAFETY, EFFICACY, OUTCOMES, PLACEBO, DRUG, 3121 General medicine, internal medicine and other clinical medicine",
author = "Manuel Pombo-Suarez and Carlos Sanchez-Piedra and Juan Gomez-Reino and Kim Lauper and Denis Mongin and Florenzo Iannone and Karel Pavelka and Nordstrom, {Dan C.} and Nevsun Inanc and Catalin Codreanu and Hyrich, {Kimme L.} and Denis Choquette and Anja Strangfeld and Leeb, {Burkhard F.} and Ziga Rotar and Ana Rodrigues and Kristianslund, {Eirik Klami} and Kvien, {Tore K.} and Ori Elkayam and Galina Lukina and Bergstra, {Sytske Anne} and Axel Finckh and Courvoisier, {Delphine Sophie}",
year = "2023",
month = feb,
doi = "10.1136/ard-2022-222835",
language = "English",
volume = "82",
pages = "175–181",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "Elsevier B.V.",
number = "2",
}